AirSculpt Technologies, Inc. (AIRS) vs Fortress Biotech, Inc. (FBIOP)

A side-by-side comparison of AirSculpt Technologies, Inc. and Fortress Biotech, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — AIRS vs FBIOP

growth of $100 · dividends reinvested · last 5y
AIRS -87.4% (-34.0%/yr)FBIOP -1.1% (-0.2%/yr)FBIOP compounded faster over this window
Log scale — wide-divergence pair
101001kStart $10020222023202420252026$13$99
AIRS FBIOP

AIRS vs FBIOP: by the numbers

  • •FBIOP is the larger company ($142M vs $135M market cap).
  • •FBIOP is profitable (163.32% net margin) while AIRS runs a net loss (-7.79%).
  • •AIRS grew revenue faster over the past five years (8.17% vs 5.39% CAGR).

Metrics side by side

Valuation

MetricAIRSFBIOP
P/E ratioN/A6.75
Forward P/EN/A7.10
P/S ratio0.892.08
P/B ratio1.290.87
EV / EBITDA438.56N/A
FCF yield0.56%88.32%

Profitability

MetricAIRSFBIOP
Gross margin57.63%62.53%
Operating margin-7.85%-111.00%
Net margin-7.79%163.32%
ROE-11.20%68.12%
ROIC-7.01%-10.85%

Growth (annualized)

MetricAIRSFBIOP
Revenue CAGR (5Y)8.17%5.39%
FCF CAGR (5Y)-52.36%N/A
Total return CAGR (5Y)N/A0.05%

Frequently asked

Which has grown faster, AIRS or FBIOP?
Over the past five years, AIRS grew revenue faster — AIRS at a 8.17% CAGR versus FBIOP at 5.39%.
Is AIRS or FBIOP more profitable?
FBIOP runs the higher net margin — AIRS at -7.79% versus FBIOP at 163.32%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.